Table 1.
Baseline Characteristic of study participants
| Healthy young | Healthy elderly | Elderly with CMD | |
|---|---|---|---|
| Age | 28.60 (3.53) | 80.7 (4.69) a | 79.3 (4.67) |
| Sex (F/M) | 5/5 | 5/5 | 6/3 |
| Abdominal obesity | 0/10 | 0/10 | 10/10 b |
| CVDs (atherosclerosis, sroke, myocardial infarction, etc.) | 0/10 | 0/10 | 0/10 |
| ALT (U/L) | 21.58 (5.28) | 16.56 (4.90) | 24.04 (15.55) |
| AST (U/L) | 20.19 (3.04) | 22.48 (4.76) | 26.39 (14.12) |
| TBIL (µmol/L) | 11.53 (3.47) | 12.45 (3.75) | 11.98 (3.21) |
| Scr (µmol/L) | 65.47 (13.16) | 71.25 (11.58) | 71.05 (16.62) |
| BUN (mmol/L) | 5.75 (1.39) | 5.50 (0.53) | 6.85 (1.88) |
| TC (mmol/L) | 4.72 (0.66) | 5.64 (1.10) a | 6.00 (1.11) |
| TG (mmol/L) | 1.08 (0.23) | 1.21 (0.32) a | 2.50 (0.89) b |
| LDL-C (mmol/L) | 3.15 (0.56) | 3.38 (0.39) | 3.59 (0.83) |
| HDL-C (mmol/L) | 1.25 (0.06) | 1.4 (0.34) | 1.11 (0.29) |
| FPG (mmol/L) | 4.58 (0.60) | 5.61 (0.27) | 10.05 (3.03) b |
Data are presented as mean (SD) except sex presented as frequency. ALT, glutamic-pyruvic transaminase; AST, glutamic-oxaloacetic transaminase; TBIL, total bilirubin; Scr, serum creatinine; BUN, blood urea nitrogen; TC, total cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; FPG, fasting plasma glucose; ap < 0.05 vs. healthy young; bp < 0.05 vs. healthy elderly